Indeed, expression of PD1 and TIM3 in tumor-infiltrating lymphocytes is associated with immune checkpoint resistance, irrespective of PD-L1 expression in tumors such non-small cell lung cancer [71]. This evidence concerns the gene HAVCR2 and neoplasm.